A Rhode Island man and his family have filed an inferior vena cava filter lawsuit against Bard claiming the manufacturer knew or should have known about the risks associated with the medical device.

Plaintiffs Peter and Lyndsay J. along with their four children have filed an inferior vena cava filter lawsuit relating to damages suffered as a result of Peter being implanted with an IVC filter.

The family seek action for damages regarding Bard’s development, testing, assembling, manufacturing, packaging, labeling, preparing, distribution, marketing, supplying and/or selling of one of their inferior vena cava (IVC) filters.

Allegations Raised in Family’s Inferior Vena Cava Filter Lawsuit

According to this inferior vena cava filter lawsuit, Peter was implanted with Bard’s G2 Filter System around March 30, 2009.

The family claims that he suffered serious and ongoing physical, emotional and economic damages as a result.

The inferior vena cava filter lawsuit claims that the G2 Filter was designed, manufactured, prepared, compounded, assembled, processed, labeled, marketed, distributed, and sold by Bard from approximately September 2005 to the present.

The purpose of the G2 Filter is the prevention of blood clots from traveling from the lower portions of the body to the heart and lungs.

One of the reasons that Peter and his family believe that Bard knew or should have known that the G2 device was defective and dangerous is that Bard allegedly failed to conduct any clinical testing, including animal testing, to determine how the IVC filter would function once implanted in the human body.

Another reason the family believe Bard should have known about the G2 Filter risks is that the IVC filter had a high rate of fracture, migration, and excessive tilting and perforation of the vena cava wall once implanted in the human body.

Bard also should have known, according to this inferior vena cava filter lawsuit, that these types of filter failures could lead to serious injuries, including death or hemorrhage as well as cardiac/pericardial tamponade and cardiac arrhythmia.

The G2 Filters, allegedly, can lead to myocardial infarction, severe and persistent pain, perforations of tissue, vessels, and organs and an inability to remove the device.

The family also believe that even though Bard designed and continued to market what they knew as a defective device, they still failed to issue a recall or notify patients and the medical community that something safer might be available.

According to the Food and Drug Administration, the most common problems reported with IVC filters include:

• IVC thrombosis
• Deep vein thrombosis (DVT)
• Access site thrombosis
• Filter migration
• Caval penetration
• IVC filter fracture

Bard has marketed the G2 Filter to have “enhanced fracture resistance,” compared to an earlier inferior vena cava filter as well as “improved centering,” and “increased migration resistance.”

Bard’s website states that the data supporting this is “on file.”

Filing an IVC Filter Lawsuit

If you or a loved one has suffered IVC filter side effects such as migration, IVC perforation, DVT or pulmonary embolism, you may have be able to file an inferior vena cava filter lawsuit.

An IVC filter lawsuit may help you obtain compensation for your medical bills, pain and suffering, lost wages and more.

The Bard Inferior Vena Cava Filter Lawsuit is Case No. 1:16-cv-00578 in the U.S. District Court for the District of Rhode Island.